Flok Health, the world’s first AI-operated physiotherapy clinic, has raised £9.5 million in an oversubscribed Series A round.
The round was led by Albion VC, with participation from existing backers Eka VC and Form Ventures, as well as new investors Mercia Ventures.
Flok Health’s pioneering clinic is the first and only AI platform in Europe to deliver entire healthcare pathways autonomously without requiring human oversight. The tech is currently available to millions of NHS patients across the UK, offering on-demand appointments for back pain with zero waitlist, via a simple mobile app.
Created by former medic and athlete, Finn Stevenson, technologist Ric da Silva, and their team of physiotherapy and AI experts, the digital clinic manipulates real footage of a human physiotherapist to simulate the experience of a live video call appointment that responds in real-time to what a patient is saying and doing.
Having halved waiting lists and delivered significant time and resource savings during a series of successful NHS rollouts, the service is now available to more than 2.4 million patients across 11 areas of the NHS.
“The most fundamental problem in healthcare today is supply-demand mismatch,” said CEO Stevenson. “Billions of people around the world suffer unnecessarily from treatable conditions, and it’s just never going to be possible for traditional clinicians to solve this one patient at a time.
“AI is a generational opportunity to close that supply-demand gap and ensure that anyone, anywhere, can get the best possible care whenever they need it. We’re particularly proud to already be scaling our AI MSK clinic in the NHS, and seeing incredible results for patients and services.
“This new funding will allow us to more rapidly scale our existing back pain service, and to expand the scope of our AI-operated clinic to fully manage new high volume clinical pathways, and new international markets.”
The AI clinic has been exclusively available to patients suffering with back pain to-date. Flok will use the new funding to accelerate scaling its existing back pain service across the UK, while also expanding its clinical and geographical scope.
Specifically, the AI technology is currently being trained in other high volume care pathways including hip and knee pain, and women’s pelvic health conditions – with all three of these new services due to launch in the UK this year.
Flok’s AI physiotherapist will then be capable of fully managing conditions that affect >20m people every year in the UK, and represent some of the highest demand services in the NHS.
Leigh Brody, investor at AlbionVC, said: “The supply-demand gap in healthcare is one of the defining challenges of our time. There are over 390,000 sitting on waiting lists in England for MSK conditions alone that are entirely treatable.
“What Finn, Ric and the team have done is demonstrate, with real patients in a real health system, that it’s possible to deliver entire care pathways autonomously, at scale, without compromising on outcomes. They’ve navigated an extraordinarily complex regulatory environment, earned the trust of NHS partners, and built something that meets patients where they are, removing the practical barriers that often exclude the most vulnerable.
“That combination of clinical rigour, operational execution and patient impact is rare. MSK is where they’ve proven the model, but the opportunity ahead is far bigger. Having seen how this team operates, we have real confidence in their ability to deliver it.”
Gigaton plans 5-fold increase in workforce after £19m Series A